Independent Portfolio Consultants’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Independent Portfolio Consultants's CELG Position: Q2 2017 in Review
Independent Portfolio Consultants increased its Celgene Corp (CELG) stake by 40% in Q2 2017, buying an estimated $75.1K and bringing the position to 2,154 shares worth $280K. The position accounts for 0.12% of the portfolio, ranked #245.
Independent Portfolio Consultants first reported a position in CELG in Q2 2014 and has held it in 13 quarters since. The position peaked at $501K in Q4 2015. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.
- Independent Portfolio Consultants held 2,154 shares of Celgene Corp worth $280K as of Q2 2017.
- Independent Portfolio Consultants bought 613 Celgene Corp shares in Q2 2017, an estimated $75.1K.
- Celgene Corp made up 0.12% of Independent Portfolio Consultants's portfolio in Q2 2017, its #245 holding.
- Independent Portfolio Consultants first reported a position in Celgene Corp in Q2 2014 and has held it in 13 quarters since.
- Independent Portfolio Consultants's Celgene Corp position peaked at $501K in Q4 2015.
- 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.
Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.